Fetal metabolic response to endogenous insulin release

Anthony F Philipps, J. W. Dubin, J. R. Raye

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The fetal metabolic response to tolbutamide-induced insulin release was evaluated in nine chronically catheterized fetal lambs. Tolbutamide produced an elevation in fetal insulin that persisted throughout the 1-hour experimental period (peak insulin concentration achieved was 76.1 ± 9.5 μU/ml). Fetal hyperinsulinemia was associated with a fall by 30 minutes in both fetal arterial and umbilical venous glucose concentrations as well as an increase in the umbilical glucose venous-arterial difference. This increase was associated with an elevation of fetal glucose uptake 65.6% ± 29.6% above control at 30 minutes after infusion. Fetal arterial oxygen content fell after tolbutamide administration and was accompanied by an increase in the umbilical venous-arterial oxygen content difference (13.0% ± 5.0% above the basal level). Despite the increased venous-arterial difference, however, no change in the umbilical oxygen consumption was noted. Isolated endogenous fetal insulin release is thus associated with a relatively rapid increase in umbilical glucose uptake as well as concomitant fetal hypoglycemia. The etiology of the mild fetal hypoxemia produced is unclear. The alterations in fetal glucose uptake in the ovine fetus after tolbutamide mimic those changes occurring after fetal exogeneous insulin infusion. These alterations strongly suggest a significant role for insulin in the modulation of fetal carbohydrate metabolism and perhaps oxygen utilization.

Original languageEnglish (US)
Pages (from-to)441-445
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume139
Issue number4
StatePublished - 1981
Externally publishedYes

Fingerprint

Umbilicus
Tolbutamide
Insulin
Glucose
Oxygen
Carbohydrate Metabolism
Hyperinsulinism
Hypoglycemia
Oxygen Consumption
Sheep
Fetus

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Fetal metabolic response to endogenous insulin release. / Philipps, Anthony F; Dubin, J. W.; Raye, J. R.

In: American Journal of Obstetrics and Gynecology, Vol. 139, No. 4, 1981, p. 441-445.

Research output: Contribution to journalArticle

@article{69d6241cee214d8fb533d3997f8266ce,
title = "Fetal metabolic response to endogenous insulin release",
abstract = "The fetal metabolic response to tolbutamide-induced insulin release was evaluated in nine chronically catheterized fetal lambs. Tolbutamide produced an elevation in fetal insulin that persisted throughout the 1-hour experimental period (peak insulin concentration achieved was 76.1 ± 9.5 μU/ml). Fetal hyperinsulinemia was associated with a fall by 30 minutes in both fetal arterial and umbilical venous glucose concentrations as well as an increase in the umbilical glucose venous-arterial difference. This increase was associated with an elevation of fetal glucose uptake 65.6{\%} ± 29.6{\%} above control at 30 minutes after infusion. Fetal arterial oxygen content fell after tolbutamide administration and was accompanied by an increase in the umbilical venous-arterial oxygen content difference (13.0{\%} ± 5.0{\%} above the basal level). Despite the increased venous-arterial difference, however, no change in the umbilical oxygen consumption was noted. Isolated endogenous fetal insulin release is thus associated with a relatively rapid increase in umbilical glucose uptake as well as concomitant fetal hypoglycemia. The etiology of the mild fetal hypoxemia produced is unclear. The alterations in fetal glucose uptake in the ovine fetus after tolbutamide mimic those changes occurring after fetal exogeneous insulin infusion. These alterations strongly suggest a significant role for insulin in the modulation of fetal carbohydrate metabolism and perhaps oxygen utilization.",
author = "Philipps, {Anthony F} and Dubin, {J. W.} and Raye, {J. R.}",
year = "1981",
language = "English (US)",
volume = "139",
pages = "441--445",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Fetal metabolic response to endogenous insulin release

AU - Philipps, Anthony F

AU - Dubin, J. W.

AU - Raye, J. R.

PY - 1981

Y1 - 1981

N2 - The fetal metabolic response to tolbutamide-induced insulin release was evaluated in nine chronically catheterized fetal lambs. Tolbutamide produced an elevation in fetal insulin that persisted throughout the 1-hour experimental period (peak insulin concentration achieved was 76.1 ± 9.5 μU/ml). Fetal hyperinsulinemia was associated with a fall by 30 minutes in both fetal arterial and umbilical venous glucose concentrations as well as an increase in the umbilical glucose venous-arterial difference. This increase was associated with an elevation of fetal glucose uptake 65.6% ± 29.6% above control at 30 minutes after infusion. Fetal arterial oxygen content fell after tolbutamide administration and was accompanied by an increase in the umbilical venous-arterial oxygen content difference (13.0% ± 5.0% above the basal level). Despite the increased venous-arterial difference, however, no change in the umbilical oxygen consumption was noted. Isolated endogenous fetal insulin release is thus associated with a relatively rapid increase in umbilical glucose uptake as well as concomitant fetal hypoglycemia. The etiology of the mild fetal hypoxemia produced is unclear. The alterations in fetal glucose uptake in the ovine fetus after tolbutamide mimic those changes occurring after fetal exogeneous insulin infusion. These alterations strongly suggest a significant role for insulin in the modulation of fetal carbohydrate metabolism and perhaps oxygen utilization.

AB - The fetal metabolic response to tolbutamide-induced insulin release was evaluated in nine chronically catheterized fetal lambs. Tolbutamide produced an elevation in fetal insulin that persisted throughout the 1-hour experimental period (peak insulin concentration achieved was 76.1 ± 9.5 μU/ml). Fetal hyperinsulinemia was associated with a fall by 30 minutes in both fetal arterial and umbilical venous glucose concentrations as well as an increase in the umbilical glucose venous-arterial difference. This increase was associated with an elevation of fetal glucose uptake 65.6% ± 29.6% above control at 30 minutes after infusion. Fetal arterial oxygen content fell after tolbutamide administration and was accompanied by an increase in the umbilical venous-arterial oxygen content difference (13.0% ± 5.0% above the basal level). Despite the increased venous-arterial difference, however, no change in the umbilical oxygen consumption was noted. Isolated endogenous fetal insulin release is thus associated with a relatively rapid increase in umbilical glucose uptake as well as concomitant fetal hypoglycemia. The etiology of the mild fetal hypoxemia produced is unclear. The alterations in fetal glucose uptake in the ovine fetus after tolbutamide mimic those changes occurring after fetal exogeneous insulin infusion. These alterations strongly suggest a significant role for insulin in the modulation of fetal carbohydrate metabolism and perhaps oxygen utilization.

UR - http://www.scopus.com/inward/record.url?scp=0019349822&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019349822&partnerID=8YFLogxK

M3 - Article

VL - 139

SP - 441

EP - 445

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -